Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Swiss National Bank Governing Council member Tschudin: Under the current circumstances, we do not want to see lower inflation.
2025-11-04
Swiss National Bank Governing Council member Tschudin: Under the current circumstances, we do not want to see lower inflation.
Back
Other News
2025-11-04
US biotechnology company Metsera: Novo Nordisk (NVO.N)'s offer is better than Pfizer's (PFE.N) revised proposal, which values the company at up to $70 per share, totaling approximately $8.1 billion.
US biotechnology company Metsera: Novo Nordisk (NVO.N)'s offer is better than Pfizer's (PFE.N) revised proposal, which values the company at up to $70 per share, totaling approximately $8.1 billion.
2025-11-04
UBS Group: Switzerland is facing threats from centers such as Singapore in the global wealth management field.
UBS Group: Switzerland is facing threats from centers such as Singapore in the global wealth management field.
Chat with us
, powered by
LiveChat